Source: Bmc medicine. Unidade: FM
Subjects: RIM, COVID-19, MORTALIDADE, FATORES DE RISCO
ABNT
FIGUEIREDO, Flavio de Azevedo et al. Development and validation of the MMCD score to predict kidney replacement therapy in COVID-19 patients. Bmc medicine, v. 20, n. 1, 2022Tradução . . Disponível em: https://doi.org/10.1186/s12916-022-02503-0. Acesso em: 12 out. 2024.APA
Figueiredo, F. de A., Ramos, L. E. F., Silva, R. T., Ponce, D., Carvalho, R. L. R. de, Schwarzbold, A. V., et al. (2022). Development and validation of the MMCD score to predict kidney replacement therapy in COVID-19 patients. Bmc medicine, 20( 1). doi:10.1186/s12916-022-02503-0NLM
Figueiredo F de A, Ramos LEF, Silva RT, Ponce D, Carvalho RLR de, Schwarzbold AV, Maurilio A de O, Scotton ALBA, Garbini AF, Aliberti MJR. Development and validation of the MMCD score to predict kidney replacement therapy in COVID-19 patients [Internet]. Bmc medicine. 2022 ; 20( 1):[citado 2024 out. 12 ] Available from: https://doi.org/10.1186/s12916-022-02503-0Vancouver
Figueiredo F de A, Ramos LEF, Silva RT, Ponce D, Carvalho RLR de, Schwarzbold AV, Maurilio A de O, Scotton ALBA, Garbini AF, Aliberti MJR. Development and validation of the MMCD score to predict kidney replacement therapy in COVID-19 patients [Internet]. Bmc medicine. 2022 ; 20( 1):[citado 2024 out. 12 ] Available from: https://doi.org/10.1186/s12916-022-02503-0